Medicare Payment Policy
Expert articles and analysis related to medicare payment policy.
AI Summary — Last 24 Hours
CMS finalized changes to the Increasing Organ Transplant Access Model, signaling continued Trump administration use of CMMI mandatory-style payment models to push specialty care providers toward access, quality, and accountability goals—important for ACOs and health systems managing high-cost ESRD and transplant populations ([CMS IOTA Model changes](https://news.google.com/rss/articles/CBMisAFBVV95cUxQNlFHU3d0OFR1TTE3Y2lPQ1Q1dmF3NnIzOGowLUpLU2p2al9MMDU4NzFSakdMcU9VYXdCM0hvQ0J5bG54ckpFZ2NhS0dXTE9WVmU4bXAtSXpCaDRsRXBTWWNTbHpwQWdsVFBod2NHTDJwcVZ0MW9LbE0zT1NHYW5PbTlvY1p3NWtabF93MFpwcTdHUTVRLXJnVF9qQmZXNU8yMjgyUkVWTXBxSm5aSmVTMdIBsAFBVV95cUxQNlFHU3d0OFR1TTE3Y2lPQ1Q1dmF3NnIzOGowLUpLU2p2al9MMDU4NzFSakdMcU9VYXdCM
Related Articles
Washington seniors face denied, delayed care under AI Medicare review program
Washington seniors face denied, delayed care under AI Medicare review program  Oregon Public Broadcasting - OPB
What's Behind CVS Health's Nearly $290 Million Medicare Fraud Judgment
What's Behind CVS Health's Nearly $290 Million Medicare Fraud Judgment  Kavout
$522M genetic testing fraud scheme targets Medicare and Medicaid; Trump drug pricing deal projected to save $64.3B over 10 years; the future of GLP-1 drugs – Morning Medical Update
$522M genetic testing fraud scheme targets Medicare and Medicaid; Trump drug pricing deal projected to save $64.3B over 10 years; the future of GLP-1 drugs – Morning Medical Update  Medical Economics
Navina Steps Up Prospective AI Risk Adjustment Push Amid Regulatory Shift
Navina Steps Up Prospective AI Risk Adjustment Push Amid Regulatory Shift  TipRanks
Polypharmacy for Older Adults With Diabetes Reaches as High As 95.3%
CMS finalizes changes to Increasing Organ Transplant Access Model
CMS finalizes changes to Increasing Organ Transplant Access Model  EIN News
Regulating Corporate Control in the U.S. Health Care System
Regulating Corporate Control in the U.S. Health Care System  The New England Journal of Medicine
Clover targets 100-150 bps SG&A improvement in 2026 while expecting full-year GAAP net income profitability
Clover targets 100-150 bps SG&A improvement in 2026 while expecting full-year GAAP net income profitability  MSN
Carbon Health Broadens Veteran Coverage and Deepens Clinical Trials Strategy in Busy Week
Carbon Health Broadens Veteran Coverage and Deepens Clinical Trials Strategy in Busy Week  TipRanks
[World Report] From hope to uncertainty: regulating novel drugs for Alzheimer's disease
Why have regulatory agencies offered differing assessments of new treatments that have brought promise to millions of people affected by Alzheimer's disease? Nayanah Siva reports.